Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results. Read why I rate NVO stock a strong buy right now.

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing ...

Viasat’s stock soared on Monday after the competitor to Starlink received an analyst endorsement from Deutsche Bank.

Johnson & Johnson has come out fighting after Pfizer announced yesterday that it is ready to launch a biosimilar competitor to ... the data from the NOR SWITCH study, which confirms ...

Leap Therapeutics (LPTX) presented updated preliminary data from Part B of the DeFianCe study, a Phase 2, open-label, global study of ...

It is the latest blow for Starbucks after millions of customres fled the brand last year due to a string of gripes.

Stanford scientists found that dramatic climate changes after the Great Dying enabled a few marine species to spread globally ...